A phase 1b study of combined angiogenesis blockade with nesvacumab, a selective monoclonal antibody (MAb) to angiopoietin-2 (Ang2) and ziv-aflibercept in patients with advanced solid malignancies Meeting Abstract
| Authors: | Papadopoulos, K. P.; Graham, D. M.; Tolcher, A. W.; Razak, A. R. A.; Patnaik, A.; Bedard, P. L.; Rasco, D. W.; Amaya, A.; Moore, K. N.; Konner, J. A.; Matei, D.; Martin, L. P.; Adriaens, L.; Brownstein, C. M.; Lowy, I.; Gao, B.; Kostic, A.; DiCioccio, A. T.; Trail, P.; Siu, L. L. |
| Abstract Title: | A phase 1b study of combined angiogenesis blockade with nesvacumab, a selective monoclonal antibody (MAb) to angiopoietin-2 (Ang2) and ziv-aflibercept in patients with advanced solid malignancies |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613202787 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.2522 |
| Notes: | Meeting Abstract: 2522 -- Source: Wos |
